Rock Springs Capital Management LP - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 51 filers reported holding NEUROCRINE BIOSCIENCES INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Rock Springs Capital Management LP ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$1,497,950
+17.4%
1,000,0000.0%0.04%
+33.3%
Q2 2023$1,276,050
-5.6%
1,000,0000.0%0.03%
-6.2%
Q1 2023$1,351,500
-14.8%
1,000,0000.0%0.03%
-15.8%
Q4 2022$1,586,500
+12.3%
1,000,0000.0%0.04%
+5.6%
Q3 2022$1,413,000
+6.4%
1,000,0000.0%0.04%
-7.7%
Q2 2022$1,328,000
+0.6%
1,000,0000.0%0.04%
+18.2%
Q1 2022$1,320,000
+5.0%
1,000,0000.0%0.03%
+13.8%
Q4 2021$1,257,000
-5.9%
1,000,0000.0%0.03%
+3.6%
Q3 2021$1,336,000
-0.8%
1,000,0000.0%0.03%
+3.7%
Q2 2021$1,347,000
-0.5%
1,000,0000.0%0.03%
-10.0%
Q1 2021$1,354,000
-2.6%
1,000,0000.0%0.03%
+3.4%
Q4 2020$1,390,000
+0.4%
1,000,0000.0%0.03%
-17.1%
Q3 2020$1,385,000
-17.2%
1,000,0000.0%0.04%
-23.9%
Q2 2020$1,673,000
+30.0%
1,000,0000.0%0.05%
-13.2%
Q1 2020$1,287,000
-16.2%
1,000,0000.0%0.05%
+8.2%
Q4 2019$1,536,000
+12.0%
1,000,0000.0%0.05%
-10.9%
Q3 2019$1,372,000
+4.2%
1,000,0000.0%0.06%
+14.6%
Q2 2019$1,317,000
-2.7%
1,000,0000.0%0.05%
-7.7%
Q1 2019$1,354,000
+13.2%
1,000,0000.0%0.05%
-7.1%
Q4 2018$1,196,000
-29.9%
1,000,0000.0%0.06%
-9.7%
Q3 2018$1,707,000
+18.0%
1,000,0000.0%0.06%
+10.7%
Q2 2018$1,446,0001,000,0000.06%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q2 2018
NameSharesValueWeighting ↓
Aequim Alternative Investments LP 24,000,000$30,877,0005.11%
Alken Asset Management Ltd 360,000$457,0001.90%
III Capital Management 3,500,000$4,481,0001.64%
SHENKMAN CAPITAL MANAGEMENT INC 3,920,000$5,113,0000.76%
CSS LLC/IL 6,842,000$8,745,0000.69%
DeepCurrents Investment Group LLC 10,408,000$13,373,0000.65%
SSI INVESTMENT MANAGEMENT LLC 4,334,000$5,554,0000.49%
WOLVERINE ASSET MANAGEMENT LLC 18,250,000$23,476,0000.34%
MACKAY SHIELDS LLC 24,612,000$31,641,0000.29%
Nicholas Investment Partners, LP 1,115,000$1,429,0000.28%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders